Tower Research Capital LLC (Trc) Novartis Ag Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Novartis Ag stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 102 shares of NVS stock, worth $10,041. This represents 0.0% of its overall portfolio holdings.
Number of Shares
102
Previous 416
75.48%
Holding current value
$10,041
Previous $44,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding NVS
# of Institutions
1,437Shares Held
131MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.2 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.18 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$797 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$688 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$568 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $212B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...